LifeStance Health Group, Inc. (LFST) Income Statement
LFST 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsLFST revenue and net income
Where LFST's revenue goes
2025Each bar shows an amount and its share of revenue. LFST kept 0.7% of revenue as net income.
LFST profit margins
LFST growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +13.9% | +18.3% | +30.4% | — |
| Gross profit | +14.6% | +24.8% | +28.0% | — |
| Operating income | — | — | +9.4% | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
LFST quarterly EPS vs estimates
LifeStance Health beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 5, 2026 (estimate $0.03).
LFST income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.42B | $1.25B | $1.06B | $859.5M | $667.5M | $377.2M | $212.5M |
| Cost of revenue | $963.2M | $848.6M | $753.6M | $622.5M | $466.0M | $242.9M | $150.1M |
| Gross profit | $461.1M | $402.4M | $302.1M | $237.0M | $201.5M | $134.3M | $62.4M |
| Sales, general & admin | $382.2M | $363.1M | $412.6M | $386.6M | $435.7M | $90.4M | $41.7M |
| Total operating expenses | $437.0M | $434.0M | $491.2M | $447.2M | $487.9M | $118.9M | $47.2M |
| Operating income | $24.1M | −$31.6M | −$189.1M | −$210.2M | −$286.4M | $15.4M | $15.2M |
| Interest expense | $11.7M | $26.5M | $21.2M | $19.9M | $38.9M | $22.1M | $5.4M |
| Income before taxes | $12.4M | −$57.6M | −$206.6M | −$232.7M | −$333.1M | −$44.4M | $7.9M |
| Income taxes | $2.7M | −$170,000 | −$20.3M | −$17.2M | −$25.9M | −$6.3M | $2.2M |
| Net income | $9.7M | −$57.4M | −$186.3M | −$215.6M | −$307.2M | −$38.1M | $5.7M |
| EBITDA | $78.8M | $39.9M | −$104.9M | −$143.6M | −$240.1M | $8.8M | $19.4M |
| EPS (diluted) | $0.14 | −$0.03 | −$0.20 | −$0.20 | −$0.84 | −$0.04 | — |
| Gross margin | 32.4% | 32.2% | 28.6% | 27.6% | 30.2% | 35.6% | 29.4% |
| Operating margin | 1.7% | −2.5% | −17.9% | −24.5% | −42.9% | 4.1% | 7.2% |
| Net margin | 0.7% | −4.6% | −17.6% | −25.1% | −46.0% | −10.1% | 2.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $435.4M | $403.5M | $382.2M | $363.8M | $345.3M | $333.0M | $325.5M | $312.7M | $312.3M | $300.4M | $280.6M | $262.9M |
| Cost of revenue | $282.3M | $267.5M | $255.9M | $247.2M | $236.9M | $223.2M | $216.0M | $212.3M | $214.5M | $205.7M | $197.3M | $186.7M |
| Gross profit | $153.0M | $135.9M | $126.3M | $116.6M | $108.4M | $109.8M | $109.4M | $100.4M | $97.8M | $94.7M | $83.3M | $76.2M |
| Sales, general & admin | $108.1M | $100.3M | $94.8M | $95.6M | $97.4M | $94.4M | $93.7M | $85.7M | $95.5M | $89.0M | $94.4M | $130.9M |
| Total operating expenses | $122.4M | $113.6M | $108.2M | $109.2M | $111.4M | $108.2M | $108.4M | $100.4M | $113.8M | $111.5M | $115.6M | $150.6M |
| Operating income | $30.7M | $22.3M | $18.1M | $7.4M | −$3.0M | $1.6M | $1.1M | $47,000 | −$15.9M | −$16.8M | −$32.3M | −$74.4M |
| Interest expense | $2.6M | $1.8M | $2.9M | $2.8M | $2.9M | $3.1M | $9.4M | $5.4M | $5.8M | $5.9M | $5.5M | $5.5M |
| Income before taxes | $27.5M | $19.8M | $15.2M | $4.6M | −$5.9M | −$1.5M | −$8.9M | −$5.4M | −$22.6M | −$20.7M | −$38.3M | −$78.0M |
| Income taxes | $3.8M | $5.5M | $3.5M | $3.5M | −$2.2M | −$2.2M | −$1.8M | $575,000 | $656,000 | $363,000 | $6.6M | −$16.4M |
| Net income | $23.6M | $14.2M | $11.7M | $1.1M | −$3.8M | $709,000 | −$7.1M | −$6.0M | −$23.3M | −$21.1M | −$45.0M | −$61.6M |
| EBITDA | $44.3M | $34.9M | $31.5M | $20.9M | $11.0M | $15.4M | $15.2M | $15.1M | $1.8M | $7.7M | −$10.6M | −$52.9M |
| EPS (diluted) | $0.06 | $0.07 | $0.09 | $0.01 | −$0.01 | $0.05 | −$0.01 | $0.03 | $0.01 | −$0.06 | −$0.12 | −$0.02 |
| Gross margin | 35.2% | 33.7% | 33.0% | 32.0% | 31.4% | 33.0% | 33.6% | 32.1% | 31.3% | 31.5% | 29.7% | 29.0% |
| Operating margin | 7.0% | 5.5% | 4.7% | 2.0% | −0.9% | 0.5% | 0.3% | 0.0% | −5.1% | −5.6% | −11.5% | −28.3% |
| Net margin | 5.4% | 3.5% | 3.1% | 0.3% | −1.1% | 0.2% | −2.2% | −1.9% | −7.5% | −7.0% | −16.0% | −23.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in LFST's financial statements (latest annual report filed February 25, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
LFST financial results
In fiscal year 2025 (ended December 31, 2025), LifeStance Health reported revenue of $1.4 billion, up 13.9% from the year before. It had net income of $9.7 million, a net profit margin of 0.7%. Diluted earnings per share came to $0.14. Over five years revenue grew at an average rate of 30.4% a year.
See the LFST stock overview for the latest quote and news, or the LFST chart for price history and technical indicators.
LFST income statement FAQ
What is LifeStance Health's annual revenue?
LifeStance Health reported total revenue of $1.4 billion for fiscal year 2025, which ended on December 31, 2025. That was up 13.9% from $1.3 billion the previous year.
Is LifeStance Health profitable?
Yes. LifeStance Health reported net income of $9.7 million in fiscal 2025, a net profit margin of 0.7%; its operating margin was 1.7%.
What is LifeStance Health's gross margin?
LifeStance Health's gross margin was 32.4% in fiscal 2025: for every $100 of revenue, LifeStance Health kept $32 after the direct cost of its products and services.
How fast is LifeStance Health growing?
Revenue grew 30.4% a year on average over the last five fiscal years, from $377.2 million to $1.4 billion.
What are LifeStance Health's earnings per share?
LifeStance Health earned $0.14 per diluted share in fiscal 2025, compared with $-0.03 a year earlier.
When will LifeStance Health report its next earnings?
LifeStance Health is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens.
When does LifeStance Health's fiscal year end?
LifeStance Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 25, 2026.